Net Loss Per Share - Schedule of Antidilutive Securities (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Number of potential common shares excluded (in shares) | 1,642,290 | 2,561,136 |
| Options to Purchase Common Stock [Member] | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Number of potential common shares excluded (in shares) | 1,606,149 | 1,371,668 |
| Restricted Stock Units [Member] | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Number of potential common shares excluded (in shares) | 36,141 | 0 |
| Warrants to Purchase Common Stock [Member] | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Number of potential common shares excluded (in shares) | 0 | 1,189,468 |